NEWSROOM
20487_FP_Header_Newsroom_Website_2400x900px

The latest from Dr. Falk Pharma

Welcome to our Newsroom, providing you with the latest news, press releases, clinical trial announcements, events, and more from Dr. Falk Pharma.

Follow us on LinkedIn!

Corporate

Merry Christmas

22.12.2022

We wish you happy holidays and all the best for 2023

More

Corporate

New Work in Freiburg

14.12.2022

Pilot space to find out which elements & spaces work for us

More

Corporate

Launch of Dr. Falk Pharma in Italy

01.12.2022

We are pleased to introduce our Italian affiliate!

More

Corporate, Press release

Collaboration and Licensing Agreement with Takeda and Zedira

20.10.2022

To Develop First-in-Class Celiac Disease Therapy

More

Corporate

Launch of Dr. Falk Pharma in France

07.10.2022

We are pleased to introduce our French affiliate!

More

Logo UEG Week
Event

UEG Week 2022

19.09.2022

Join us from October 8 – 11 in Vienna on booth no. 43 or virtually!

More

Logo Zedira
Press release, Study

NAFLD: Phase 2a proof of concept study of ZED1227

01.07.2022

Dr. Falk Pharma and Zedira announce trial start for the treatment of non-alcoholic fatty liver disease. First patient enrolled in April.

More

Event

International Liver Congress™ in London

03.06.2022

We are proud to be a sponsor and look forward to seeing you in person on our booth no. 69 or online, 22-26 June 2022!

More

Event

Digestive Disease Week® 2022

23.05.2022

We look forward to 2 exciting presentations on day 4 of this year’s DDW!

More

Press release, Indication

Have difficulty swallowing food?

10.05.2022

Difficulty swallowing and pain while eating may be warning signs of eosinophilic esophagitis (EoE). The first EoE Day will be held on May 22, 2022.

More

Corporate, Press release

Response to the Ukraine crisis

18.03.2022

Dr. Falk Pharma supports APOTHEKER HELFEN e.V.

More

Corporate, Press release

Future starts here

24.02.2022

Plans for the future Falk Campus in Freiburg-Nord finalized.

More

ECCO logo 2022
Event

ECCO 2022

09.02.2022

Online, from February 16 to 19, 2022. We look forward to seeing you!

More

Prometheus Logo
Press release

Together we advance PR600

03.01.2022

Investigational New Drug Application for PR600 expected in 3Q 2022.

More